Eastover Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-73,415
| Closed | -$4.26M | – | 45 |
|
|
2023
Q3 | $4.26M | Buy |
73,415
+2,363
| +3% | +$137K | 2.56% | 23 |
|
|
2023
Q2 | $4.54M | Buy |
71,052
+311
| +0.4% | +$19.9K | 2.42% | 26 |
|
|
2023
Q1 | $4.9M | Buy |
70,741
+1,355
| +2% | +$93.9K | 2.74% | 23 |
|
|
2022
Q4 | $4.99M | Buy |
69,386
+770
| +1% | +$55.4K | 2.86% | 23 |
|
|
2022
Q3 | $4.78M | Buy |
68,616
+1,058
| +2% | +$73.8K | 2.98% | 20 |
|
|
2022
Q2 | $5.2M | Sell |
67,558
-5,610
| -8% | -$432K | 3.17% | 18 |
|
|
2022
Q1 | $5.34M | Buy |
73,168
+8,414
| +13% | +$614K | 2.82% | 19 |
|
|
2021
Q4 | $4.04M | Buy |
64,754
+1,975
| +3% | +$123K | 2.33% | 24 |
|
|
2021
Q3 | $3.72M | Buy |
62,779
+241
| +0.4% | +$14.3K | 2.42% | 25 |
|
|
2021
Q2 | $4.18M | Buy |
62,538
+3,619
| +6% | +$242K | 2.71% | 20 |
|
|
2021
Q1 | $3.72M | Sell |
58,919
-1,984
| -3% | -$125K | 2.63% | 22 |
|
|
2020
Q4 | $3.78M | Buy |
60,903
+73
| +0.1% | +$4.53K | 2.62% | 21 |
|
|
2020
Q3 | $3.67M | Buy |
60,830
+1,321
| +2% | +$79.6K | 2.79% | 22 |
|
|
2020
Q2 | $3.5M | Buy |
59,509
+1,990
| +3% | +$117K | 2.89% | 19 |
|
|
2020
Q1 | $3.21M | Buy |
+57,519
| New | +$3.21M | 3.11% | 13 |
|